Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratorios Wassermann was a pharmaceutical company with a significant historical presence in the European healthcare sector, specifically in Spain and Italy. The company specialized in the development, manufacturing, and commercialization of a wide range of pharmaceutical products, with a particular focus on gastroenterology, respiratory diseases, and anti-infectives. In 1997, the Spanish operations of Laboratorios Wassermann were acquired by Almirall, a leading Spanish pharmaceutical firm, as part of a strategic consolidation. This acquisition allowed Almirall to integrate Wassermann's established product lines and strengthen its market position in Southern Europe. Currently, the company's legacy assets and brands are managed by its successor organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratorios Wassermann.